Search clinical trials for: Anthracyclines

Total 96 results

The University of Texas Health Science Center,...
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Stem Cell Injection in Cancer Survivors (SENECA)

Cardiomyopathy Due to Anthracyclines

United States
Eisai Inc.

Completed

E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes

Metastatic Breast Cancer

Poland, Ukraine, United States, Taiwan, Spain, Argentina, Bulgaria, Romania, South Africa, Australia, Canada, Singapore, Russian Federation, Brazil, Germany, Hungary, Italy, Israel, Greece, Mexico, Belgium, Czechia, France
Horus University

Completed

Evaluation of the Cardioprotective Effect of L-carnitine and Silymarin in Patients Receiving Anthracycline Chemotherapy

Breast Cancer

Egypt
Fudan University

Completed

Study Comparing Paclitaxel Plus Carboplatin Versus Anthracyclines Followed by Docetaxel as Adjuvant Chemotherapy for Triple Negative Breast Cancer (PATTERN)

Breast Cancer
Vilnius University

Unknown

Ivabradine to Prevent Anthracycline-induced Cardiotoxicity

Patients With Cancer

Lithuania
Xijing Hospital

Unknown

Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer

Breast Cancer

China
Stony Brook University
Gilead Sciences

Unknown

Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines

Heart Failure | Breast Cancer | Biomarkers | Cardiotoxicity | Echocardiography | Anthracycline Induced Cardiomyopathy

United States
The Hospital for Sick Children
Canadian Institutes of Health Research (CIHR); London Health Sciences Centre; Children's Hospital of Eastern Ontario and other collaborators

Completed

Preventing Cardiac Sequelae in Pediatric Cancer Survivors (PCS2)

Anthracycline-induced Cardiotoxicity

United States, Canada
University Health Network, Toronto
Canadian Institutes of Health Research (CIHR); MSH-UHN AMO Innovation Fund

Terminated

Efficacy of Cardio-Oncology Rehabilitation Exercise for Women With Breast Cancer and Treatment Related Cardiotoxicity (CORE)

Breast Cancer | Heart Failure, Systolic | Left Ventricular Dysfunction

Canada
Eisai Co., Ltd.

Completed

Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes

Breast Cancer | Breast Tumors | Triple Negative Breast Cancer | Cancer of Breast | HER2-Negative Breast Cancer

China
Centre Jean Perrin

Terminated

Phase II Pilot Study Assessing Efficacy of a Cisplatin - Metronomic Cyclophosphamide Treatment in Patients With Metastatic Triple Negative Breast Cancer Resistant to Anthracyclines and Taxanes

Metastatic Breast Cancer

France
Chulalongkorn University

Completed

Walking Meditation Exercise in Breast Cancer Patients

Breast Cancer

Thailand
Tan Tock Seng Hospital

Unknown

A Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and Taxanes

Breast Cancer

Singapore, Taiwan
Zhejiang Cancer Hospital

Unknown

Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast Cancer (ACCN)

Neoadjuvant Therapy

China
Assiut University

Unknown

Early Detection of Cardiomyopathy by Speckle Echo, High Sensitive Troponin and Cardiac Ryanodine Receptors

Chemotherapy Effect
SOLTI Breast Cancer Research Group
Schering-Plough

Completed

Caelyx as Primary Treatment for Patients With Breast Cancer and a History of Heart Disease and/or Age Over 65 Years (CAPRICE)

Breast Cancer

Spain
Tao OUYANG

Completed

A Phase Ⅱ Study of an All-Oral Combination of Low-dose Etoposide/Capecitabine in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines and/or Taxanes

Metastatic Breast Cancer

China
Versailles Hospital

Completed

Assessment of Global Longitudinal Strain for the Prediction of Anthracycline Induced Cardiotoxicity (Anthracardio)

Cardiovascular Diseases

France
PharmaMar

Completed

Study in Patients With Advanced Soft Tissue Sarcoma (STS) After Failure of Anthracyclines and/or Ifosfamide

Soft Tissue Sarcoma

Netherlands
West Pomeranian Cancer Center
Pomeranian Medical University Szczecin

Completed

Circulating MicroRNA as Biomarker of Cardiotoxicity in Breast Cancer

Breast Cancer

Poland
Majd Makhoul

Withdrawn

Cardiac 3D MRI in Pediatric Cancer Patients

Childhood Cancer

United States
The Netherlands Cancer Institute
University Medical Center Groningen

Unknown

Identifying Subgroups With High Cardiovascular Risk in Breast Cancer Survivors (HARBOR)

Cardiovascular Diseases | Breast Neoplasms

Netherlands
Centre Jean Perrin

Terminated

Phase II Pilot Study Assessing Efficacy of a Cisplatin - Métronomic Cyclophosphamide Treatment in Patients With Stade IV Triple Negative Breast Cancer Secondary Resistant to Anthracyclines and Taxanes (META2)

Metastatic Breast Cancer

France
Instituto do Cancer do Estado de São Paulo

Withdrawn

Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer

Breast Cancer | HER-2 Positive Breast Cancer

Brazil
Centre Henri Becquerel
Ligue contre le cancer, France

Terminated

Early Assessment of Anthracycline-induced Cardiotoxicity (CARDIOTOX)

Lymphoma | Heart Failure, Congestive

France
Teva Pharma

Completed

Prospective Observational Study in Patients With Metastatic Breast Cancer Treated With Anthracyclines

Metastatic Breast Cancer

Belgium
Institut Bergonié

Completed

Evolution Natriuretic Peptide Concentrations of B-type (BNP) During General Anesthesia Under Propofol and Sevoflurane Association in Patients Previously Sensitized to Anthracyclines (PEPNATB)

Breast Cancer

France
Onxeo

Completed

A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines

Extravasation

Denmark, Germany, Italy, Netherlands, Poland
Onxeo

Completed

Efficacy of TopotectTM (Dexrazoxane) for Accidental Extravasation of Anthracyclines

Anthracycline Extravasation

Denmark
Medifocus, Inc.

Unknown

Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors (Medifocus301)

Breast Cancer

United States, Canada
Merck Sharp & Dohme LLC

Terminated

Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)

Breast Neoplasm
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

Extravasations of Anthracycline Anti-cancer Agents

Japan
German Breast Group
Novartis Pharmaceuticals; Austrian Breast & Colorectal Cancer Study Group

Completed

Postoperative Use of Zoledronic Acid in Breast Cancer Patients After Neoadjuvant Chemotherapy (NATAN)

Breast Cancer

Germany, Austria
University Hospital, Akershus
University of Oslo; AstraZeneca; Norwegian Cancer Society

Completed

Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy (PRADA)

Heart Failure | Breast Cancer

Norway
National Research Center for Hematology, Russia

Unknown

3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia

Acute Myeloid Leukemia

Russian Federation
Philogen S.p.A.

Terminated

Combination Therapy of F16IL2 and Doxorubicin in Solid Tumour Patients

Breast Cancer | Advanced Solid Tumor

Italy
St. Jude Children's Research Hospital

Completed

Resistance and Aerobic Exercise for Subclinical Anthracycline Cardiomyopathy

Cardiomyopathy

United States
Baylor Research Institute

Completed

Clofarabine and Ara-C for the Treatment of Relapsed AML and Untreated MDS

Myelodysplastic Syndromes | Acute Myelogenous Leukemia | Chronic Myelogenous Leukemia

United States
University Hospital Muenster

Completed

Pharmacokinetic Study of Doxorubicin in Children With Cancer (Doxo)

Soft Tissue Sarcoma | Acute Lymphoblastic Leukemia | Neuroblastoma | Wilms Tumor

Germany, France, United Kingdom, Italy
S. Maria Hospital, Terni

Terminated

Aprepitant in the Prevention of Delayed Emesis Induced by Cyclophosphamide Plus Anthracyclines in Breast Cancer Patients

Emesis

Italy
University Hospital Muenster
Deutsche Krebshilfe e.V., Bonn (Germany)

Unknown

Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents

Myeloid Leukemia

Germany
Fudan University

Terminated

Dexrazoxane as a Protective Agent in Anthracycline Treated Breast Cancer (cardioprotec)

Breast Cancer

China
University of Calgary

Terminated

Assessment of Cardiotoxicity After Chemotherapy for Breast Cancer by Cardio-vascular Magnetic Resonance (MR) (Cardiotox)

Breast Cancer

Canada
Johnson & Johnson Pharmaceutical Research & Development...
Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USA

Completed

Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

Multiple Myeloma | Myeloma | M-Protein | Myeloma Proteins
Acute Leukemia French Association
Assistance Publique - Hôpitaux de Paris

Completed

Treatment of Acute Myeloid Leukemia (AML) in Adults 50 to 70 Years, Study of Two Anthracyclines and the Interest of Maintenance Treatment With Interleukin 2 (ALFA 9801)

Acute Myeloid Leukemia

France
Eli Lilly and Company

Completed

Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes

Metastatic Breast Cancer

Saudi Arabia

3

Subscribe